Literature DB >> 12872966

Evaluation of aerosol spray and intramuscular injection of bacteriophage to treat an Escherichia coli respiratory infection.

W E Huff1, G R Huff, N C Rath, J M Balog, A M Donoghue.   

Abstract

Two studies were conducted to determine the efficacy of either aerosol or i.m. injection of bacteriophage to treat an Escherichia coli respiratory infection in broiler chickens. An additional two studies were conducted to enumerate the bacteriophage in the blood of birds at 1, 2, 3, 4, 5, 6, 24, and 48 h after being sprayed or injected i.m. with bacteriophage. Five birds were bled at each period. In study 1, there were 10 treatments with three replicate pens of 10 birds. The treatments consisted of an untreated control, heat-killed bacteriophage spray, active bacteriophage spray, E. coli challenge at 7 d of age, and E. coli challenge followed by spraying the birds with heat-killed bacteriophage or active bacteriophage at 2, 24, or 48 h after challenge. In study 2 there were 11 treatments with three replicate pens of 10 birds per pen. The treatments were untreated controls, birds injected i.m. in the thigh with heat-killed or active bacteriophage, E. coli challenge at 7 d of age, PBS challenge, E. coli challenge followed by injection of heat-killed or active bacteriophage immediately after challenge or at 24 or 48 h after challenge. In both studies the E. coli challenge consisted of injecting 10(4) cfu into the thoracic air sac. Treatment of this severe E. coli infection with the bacteriophage aerosol spray significantly reduced mortality from 50 to 20% when given immediately after the challenge but had little treatment efficacy when administered 24 or 48 h after challenge. The i.m. injection of bacteriophage significantly reduced mortality from 53 to 17%, 46 to 10%, and 44 to 20% when given immediately, 24, or 48 h after challenge, respectively. Only a few birds sprayed with bacteriophage had detectable bacteriophage in their blood with an average of 96 pfu/mL 1 h after bacteriophage administration, and no bacteriophage was detected 24 and 48 h after bacteriophage administration. All birds injected i.m. with bacteriophage had detectable levels of bacteriophage in their blood at levels of 10(4) pfu/mL of blood up to 6 h after bacteriophage administration, and four of the five birds had detectable bacteriophage in their blood at an average level of 70 pfu/mL of blood 24 h after bacteriophage administration. The relative inefficiency of the spray treatment to the i.m. injection treatment may be due to the inability to get bacteriophage into the blood at high concentrations when the birds are sprayed versus the consistent high titers achieved with the i.m. injection of bacteriophage. These data provide support to the concept that bacteriophage may be an effective alternative to antibiotics in animal production when they are administered in a way that delivers high titers of the bacteriophage to the critical site of the bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12872966     DOI: 10.1093/ps/82.7.1108

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  20 in total

Review 1.  Enhancing the utility of existing antibiotics by targeting bacterial behaviour?

Authors:  Geraint B Rogers; Mary P Carroll; Kenneth D Bruce
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 2.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

3.  Natural and Induced Antibodies Against Phages in Humans: Induction Kinetics and Immunogenicity for Structural Proteins of PB1-Related Phages.

Authors:  Katarzyna Hodyra-Stefaniak; Zuzanna Kaźmierczak; Joanna Majewska; Sanna Sillankorva; Paulina Miernikiewicz; Ryszard Międzybrodzki; Andrzej Górski; Joana Azeredo; Rob Lavigne; Dorota Lecion; Sylwia Nowak; Marek Harhala; Patryk Waśko; Barbara Owczarek; Katarzyna Gembara; Krystyna Dąbrowska
Journal:  Phage (New Rochelle)       Date:  2020-06-16

4.  Phage Therapy - Everything Old is New Again.

Authors:  Andrew M Kropinski
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

5.  Microneedle-mediated transdermal bacteriophage delivery.

Authors:  Elizabeth Ryan; Martin J Garland; Thakur Raghu Raj Singh; Eoin Bambury; John O'Dea; Katarzyna Migalska; Sean P Gorman; Helen O McCarthy; Brendan F Gilmore; Ryan F Donnelly
Journal:  Eur J Pharm Sci       Date:  2012-06-30       Impact factor: 4.384

Review 6.  The factors affecting effectiveness of treatment in phages therapy.

Authors:  Mai Huong Ly-Chatain
Journal:  Front Microbiol       Date:  2014-02-18       Impact factor: 5.640

7.  Effects of bacteriophage supplementation on egg performance, egg quality, excreta microflora, and moisture content in laying hens.

Authors:  P Y Zhao; H Y Baek; I H Kim
Journal:  Asian-Australas J Anim Sci       Date:  2012-07       Impact factor: 2.509

Review 8.  Natural solution to antibiotic resistance: bacteriophages 'The Living Drugs'.

Authors:  Sabah A A Jassim; Richard G Limoges
Journal:  World J Microbiol Biotechnol       Date:  2014-04-30       Impact factor: 3.312

9.  Bacteriophages and their role in food safety.

Authors:  Sanna M Sillankorva; Hugo Oliveira; Joana Azeredo
Journal:  Int J Microbiol       Date:  2012-12-18

Review 10.  Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status.

Authors:  Sami Hraiech; Fabienne Brégeon; Jean-Marc Rolain
Journal:  Drug Des Devel Ther       Date:  2015-07-16       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.